Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1985 1
1986 1
1987 2
1988 2
1989 2
1990 5
1991 6
1992 8
1993 3
1994 13
1995 10
1996 21
1997 13
1998 13
1999 17
2000 19
2001 14
2002 19
2003 28
2004 31
2005 41
2006 47
2007 55
2008 68
2009 107
2010 128
2011 151
2012 157
2013 207
2014 227
2015 285
2016 296
2017 362
2018 431
2019 451
2020 627
2021 643
2022 843
2023 766
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

5,500 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: xiong j. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate.
Wu YQ, Zhang CS, Xiong J, Cai DQ, Wang CZ, Wang Y, Liu YH, Wang Y, Li Y, Wu J, Wu J, Lan B, Wang X, Chen S, Cao X, Wei X, Hu HH, Guo H, Yu Y, Ghafoor A, Xie C, Wu Y, Xu Z, Zhang C, Zhu M, Huang X, Sun X, Lin SY, Piao HL, Zhou J, Lin SC. Wu YQ, et al. Among authors: xiong j. Cell Res. 2023 Nov;33(11):835-850. doi: 10.1038/s41422-023-00874-4. Epub 2023 Sep 19. Cell Res. 2023. PMID: 37726403 Free PMC article.
Computational holographic ghost diffraction.
Ye Z, Hou W, Zhao J, Wang HB, Xiong J. Ye Z, et al. Among authors: xiong j. Opt Lett. 2023 Apr 1;48(7):1618-1621. doi: 10.1364/OL.484537. Opt Lett. 2023. PMID: 37221724
How Rice Plants Response to Abiotic Stresses.
Feng B, Xiong J, Tao L. Feng B, et al. Among authors: xiong j. Int J Mol Sci. 2023 Aug 15;24(16):12806. doi: 10.3390/ijms241612806. Int J Mol Sci. 2023. PMID: 37628985 Free PMC article.
Painful ulcers on the penis.
He Y, Jiang MJ, Xiong JS, Wang HS. He Y, et al. Among authors: xiong js. BMJ. 2023 May 11;381:e071601. doi: 10.1136/bmj-2022-071601. BMJ. 2023. PMID: 37169374 No abstract available.
Piezo1 opposes age-associated cortical bone loss.
Li X, Zhang C, Bowman HH, Stambough JB, Stronach BM, Mears SC, Barnes LC, Ambrogini E, Xiong J. Li X, et al. Among authors: xiong j. Aging Cell. 2023 Jun;22(6):e13846. doi: 10.1111/acel.13846. Epub 2023 May 5. Aging Cell. 2023. PMID: 37147884 Free PMC article.
First-Row Transition Metals for Catalyzing Oxygen Redox.
Wang H, Pei Y, Wang K, Zuo Y, Wei M, Xiong J, Zhang P, Chen Z, Shang N, Zhong D, Pei P. Wang H, et al. Among authors: xiong j. Small. 2023 Nov;19(46):e2304863. doi: 10.1002/smll.202304863. Epub 2023 Jul 19. Small. 2023. PMID: 37469215 Review.
5,500 results